Literature DB >> 19904255

Impact of reporting estimated glomerular filtration rate: it's not just about us.

Lesley A Stevens1, Andrew S Levey.   

Abstract

The reporting of estimated glomerular filtration rate (eGFR) is a key component of a public-health strategy for chronic kidney disease (CKD). Jain and colleagues show that eGFR reporting in Ontario increased referrals to nephrologists by 23 consults per year, equivalent to 2.9 additional consults per 100,000 population. In our view, a complete assessment requires a broader perspective. Most patients with CKD do not require referral to a nephrologist. Improving outcomes requires coordinated efforts of all physicians.

Entities:  

Mesh:

Year:  2009        PMID: 19904255     DOI: 10.1038/ki.2009.143

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  Advances in glomerular filtration rate-estimating equations.

Authors:  Lesley A Stevens; Smita Padala; Andrew S Levey
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

2.  The value of a formula including haematocrit, blood urea and gender (HUGE) as a screening test for chronic renal insufficiency.

Authors:  J A Alvarez-Gregori; N R Robles; C Mena; R Ardanuy; R Jauregui; J F Macas-Nu Nunez
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

3.  Warfarin dosing in patients with impaired kidney function.

Authors:  Nita A Limdi; Mohit A Limdi; Larisa Cavallari; Aaron M Anderson; Michael R Crowley; Melissa F Baird; Michael Allon; T Mark Beasley
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

4.  CKD Express © - A New IT-Software Proposed for a Paradigm Change in CKD Care.

Authors:  Macaulay Ac Onuigbo
Journal:  Open Med Inform J       Date:  2012-08-10

5.  Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study.

Authors:  Khaled Abdel-Kader; Gary S Fischer; James R Johnston; Chen Gu; Charity G Moore; Mark L Unruh
Journal:  BMC Nephrol       Date:  2011-03-15       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.